Skip to main content
Figure 1 | European Journal of Medical Research

Figure 1

From: Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study

Figure 1

Study flow chart. "Other" reasons for discontinuation included non-compliance, investigator's discretion, withdrawn consent (n = 2 each), resistant to lamivudine or stavudine, virological failure, protocol deviation and missing at least two visits without sufficient reason (n = 1 each).

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us